# Liposomes Sector

Canonical URL: https://biopharmsignal.com/sector/liposomes

Liposomes includes companies using lipid vesicles as a delivery or formulation technology for therapeutic payloads. These approaches are often used to improve distribution, tolerability, or exposure profiles across established and experimental drug categories.

Companies currently grouped under Liposomes: 1

## Recent Sector News

- 2026-07-01 12:00 EST — PCRX — [Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-unitedhealthcare-now-provides-separate-reimbursemen-87b0c6a8) — Source: Pacira BioSciences
- 2026-06-30 11:30 EST — PCRX — [Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-agreement-to-divest-its-iovera-business-to-zimmer-b-e7793cda) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Announces Stockholders Have Elected All Three of the Company's Director Nominees at Annual Meeting](https://biopharmsignal.com/news/PCRX/pacira-biosciences-announces-stockholders-have-elected-all-three-of-the-company-s-director-nominees-at-annual-meeting) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reminds-stockholders-to-vote-the-blue-proxy-card-for-the-election-of-the-company-s-highly-qualified-nominees-ahead-of-its-annual-meeting) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees](https://biopharmsignal.com/news/PCRX/pacira-biosciences-highlights-leading-independent-proxy-advisory-firm-iss-recommendation-to-vote-for-all-of-pacira-s-director-nominees) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees](https://biopharmsignal.com/news/PCRX/leading-independent-proxy-advisory-firm-glass-lewis-recommends-stockholders-vote-for-all-of-pacira-s-director-nominees) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees](https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders-reiterating-confidence-in-the-company-s-strategic-direction-and-highly-qualified-nominees) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-real-world-study-showing-exparelr-use-was-associated-with-reduced-opioid-use-and-healthcare-costs-in-patients-undergoing-total-shoulder-arthroplasty) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy](https://biopharmsignal.com/news/PCRX/pacira-biosciences-sets-the-record-straight-regarding-doma-s-misleading-statements-about-pacira-s-intellectual-property-strategy) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders](https://biopharmsignal.com/news/PCRX/pacira-biosciences-files-investor-presentation-highlighting-successful-execution-of-its-long-term-strategy-to-drive-value-for-all-stockholders) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences](https://biopharmsignal.com/news/PCRX/pacira-biosciences-to-participate-in-fireside-chats-at-three-upcoming-healthcare-conferences) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees](https://biopharmsignal.com/news/PCRX/pacira-biosciences-sends-letter-to-stockholders-reiterating-superior-qualifications-of-its-board-nominees) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reaffirms-commitment-to-shareholder-value-creation) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting](https://biopharmsignal.com/news/PCRX/pacira-biosciences-to-present-real-world-data-on-exparelr-showing-reduced-cost-of-care-at-orthopaedic-research-society-2026-annual-meeting) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/PCRX/pacira-biosciences-to-participate-in-fireside-chat-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures](https://biopharmsignal.com/news/PCRX/pacira-presents-real-world-data-on-exparelr-showing-lower-total-healthcare-costs-in-outpatient-total-hip-and-knee-arthroplasty-procedures) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026](https://biopharmsignal.com/news/PCRX/pacira-to-report-first-quarter-2026-financial-results-on-thursday-april-30-2026) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Mails Letter to Stockholders](https://biopharmsignal.com/news/PCRX/pacira-biosciences-mails-letter-to-stockholders) — Source: Pacira BioSciences
- 2026-06-25 13:46 EST — PCRX — [Pacira BioSciences Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PCRX/pacira-biosciences-reports-first-quarter-2026-financial-results) — Source: Pacira BioSciences

## Companies

- [PCRX](https://biopharmsignal.com/company/PCRX) — Pacira BioSciences